Axsome Therapeutics, Inc.
AXSM
$121.91
$0.260.21%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.37% | 20.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.37% | 20.19% | |||
| Cost of Revenue | 24.62% | 4.74% | |||
| Gross Profit | 12.38% | 21.76% | |||
| SG&A Expenses | 18.53% | -7.72% | |||
| Depreciation & Amortization | 0.06% | 1.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.47% | -7.39% | |||
| Operating Income | -33.31% | 39.08% | |||
| Income Before Tax | -15.83% | 18.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.96% | 18.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.96% | 18.58% | |||
| EBIT | -33.31% | 39.08% | |||
| EBITDA | -34.83% | 40.13% | |||
| EPS Basic | -15.00% | 19.54% | |||
| Normalized Basic EPS | -31.33% | 38.27% | |||
| EPS Diluted | -15.00% | 19.54% | |||
| Normalized Diluted EPS | -31.33% | 38.27% | |||
| Average Basic Shares Outstanding | 0.83% | 1.19% | |||
| Average Diluted Shares Outstanding | 0.83% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
